Cipla’s net sales jumped 12% to Rs 3,846 crore during the April-June quarter
Bengaluru: Cipla Ltd, India’s third-largest drugmaker by market capitalisation, posted a more than 10 percent rise in its first-quarter profit on Wednesday, well above analysts’ expectations. Net profit came in at Rs 451 crore in the three months ended 30 June, compared with Rs 409 crore a year ago, the company said in a statement.
Analysts on average had expected a profit of Rs 391 crore, Thomson Reuters Eikon data showed.
Net sales jumped 12% to Rs 3,846 crore during the April-June quarter, against the year-ago period.